-
公开(公告)号:KR1020020068148A
公开(公告)日:2002-08-27
申请号:KR1020010008424
申请日:2001-02-20
Applicant: 동화약품주식회사
IPC: C12N15/866
CPC classification number: C12N15/866 , C07K1/22 , C07K14/005 , C07K2319/00 , C12N5/0601 , C12N2730/10134 , C12N2760/10134
Abstract: PURPOSE: Provided is a divalent vaccine against hepatitis B and hepatitis D and a method for preparing it in high yield, thereby preventing hepatitis B and hepatitis D simultaneously. CONSTITUTION: Baculovirus transition vector, pVLHBs(WT)-HDs, contains HBV surface antigen coding gene having 158-836 nt region of SEQ ID NO:1 and HDV delta antigen coding gene having 1601-1016 nt region of SEQ ID NO:7. Recombinant baculovirus is prepared by transfection with the baculovirus transition vector. The divalent vaccine is expressed in a transfected insect cells by recombinant baculovirus.
Abstract translation: 目的:提供一种针对乙型肝炎和丙型肝炎的二价疫苗及其高产率制备方法,从而同时预防乙肝和丙型肝炎。 构成:杆状病毒转移载体pVLHB(WT)-HDs含有具有SEQ ID NO:1具有158-836nt区域的HBV表面抗原编码基因和具有SEQ ID NO:7的1601-1016nt区域的HDVδ抗原编码基因。 通过用杆状病毒转染载体转染制备重组杆状病毒。 二价疫苗通过重组杆状病毒在转染的昆虫细胞中表达。
-
公开(公告)号:KR100454867B1
公开(公告)日:2004-11-03
申请号:KR1020010008424
申请日:2001-02-20
Applicant: 동화약품주식회사
IPC: C12N15/866
Abstract: PURPOSE: Provided is a divalent vaccine against hepatitis B and hepatitis D and a method for preparing it in high yield, thereby preventing hepatitis B and hepatitis D simultaneously. CONSTITUTION: Baculovirus transition vector, pVLHBs(WT)-HDs, contains HBV surface antigen coding gene having 158-836 nt region of SEQ ID NO:1 and HDV delta antigen coding gene having 1601-1016 nt region of SEQ ID NO:7. Recombinant baculovirus is prepared by transfection with the baculovirus transition vector. The divalent vaccine is expressed in a transfected insect cells by recombinant baculovirus.
Abstract translation: 目的:提供一种抗乙型肝炎和丁型肝炎的二价疫苗及其高产率制备方法,由此同时预防乙型肝炎和丁型肝炎。 构成:杆状病毒转移载体pVLHBs(WT)-HDs包含具有SEQ ID NO:1的158-836nt区域的HBV表面抗原编码基因和具有SEQ ID NO:7的1601-1016nt区域的HDVδ抗原编码基因。 通过用杆状病毒转移载体转染来制备重组杆状病毒。 二价疫苗通过重组杆状病毒在转染的昆虫细胞中表达。
-